Page 9 of 13
The Journal of Organic Chemistry
(d, J = 12.9 Hz), 128.8, 126.8, 119.1 (d, J = 88.6 Hz), 116.2,
N, 4.66; S, 5.34; found (%):C, 71.82; H, 5.34; N, 4.48; S, 5.29.
21.4, 9.7 (d, J = 57.7 Hz). 31P NMR (162 MHz, CDCl3) δ [ppm]
HRMS (ESI) m/z: [M]+ calcd for: C25H22P+, 353.1454; found,
653.1451. [M]− calcd for C12H11N2O2S−, 247.0547; found,
247.0546.
1
2
3
4
5
6
7
8
−1
휈
= +21.4. IR (ATR): (cm ) = 2965 (w), 2895 (w), 1640 (w),
1587 (m), 1515 (w), 1482 (m), 1438 (m), 1314 (s), 1240 (s),
1215 (m), 1165 (w), 1118 (vs), 1082 (vs), 1055 (m), 1022 (w),
990 (m-s), 968 (m), 931 (m), 914 (m), 860 (w), 830 (w), 815
(w), 798 (w), 778 (w), 763 (w), 745 (w), 719 (m), 696 (w), 690
(w), 665 (w). Elemental analysis: C31H29N2O2PS (524.62 g
mol−1): Calc. (%): C, 70.97; H, 5.57; N, 5.34; S, 6.11; found
(%): C, 71.04; H, 5.61; N, 5.31; S, 6.23. HRMS (ESI) m/z: [M]+
calcd for C19H18P+, 277.1146; found, 277.1138. [M]− calcd for
C12H11N2O2S−, 247.0547; found, 247.0547.
1,3-Diethyl-benzimidazolium ((4-methoxyphenyl)sulfonyl)
(pyridin-4-yl) amide (6ce). Sodium hydroxide (0.088 g, 2.2
mmol, 1.1 eq) was dissolved in 5 mL H2O and this solution was
added to 0.529 g of sulfonamide 8c (2.0 mmol, 1.0 eq) with
additional 5 mL of H2O. After 15 min stirring at room
temperature, a solution of 0.510 g 1,3-diethyl-benzimidazolium
bromide 26 (2.0 mmol, 1.0 eq) in 5 mL of CH2Cl2 were added
with further 5 mL of CH2Cl2 and the resulting mixture was
stirred for 15 min. Extraction with 40 mL CH2Cl2, drying of the
organic phase over Na2SO4 (with addition of 4 pellets of
activated charcoal) and reduction of the solvent gave a
concentrated, yellow solution. The product was crystallized by
layering of toluene/hexane (10/1) on top to yield 0.363 g
catalyst 6ce (0.83 mmol, 41%) in the form of light-yellow
crystals with mp: 144 – 146 °C. 1H NMR (400 MHz, CDCl3) δ
[ppm] = 10.53 (s, 1H), 7.97 (dd, J = 5.0, 1.4 Hz, 2H), 7.83 (dd,
J = 8.8, 4.8 Hz, 2H), 7.70 – 7.55 (m, 4H, H-13), 6.81 (dd, J =
8.8, 4.9 Hz, 2H), 6.75 (dd, J = 4.9, 1.5 Hz, 2H), 4.51 (q, J = 7.3
Hz, 4H), 3.75 (s, 3H), 1.58 (t, J = 7.3 Hz, 6H). 13C{1H} NMR
(101 MHz, CDCl3) δ [ppm] = 161.0, 157.0, 149.5, 142.4, 137.4,
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1,3-Diethyl-benzimidazolium pyridin-4-yl(tosyl)amide (6be).
0.110 g Sodium hydroxide (2.75 mmol, 1.1 eq) were dissolved
in 5 mL H2O and this solution was added to 0.621 g of
sulfonamide 8b (2.50 mmol, 1.0 eq) with additional 5 mL of
H2O. After 15 min stirring at room temperature, a solution of
0.638 g 1,3-diethyl-benzimidazolium bromide 26 (2.5 mmol,
1.0 eq) in 5 mL of CH2Cl2 were added with further 5 mL of
CH2Cl2 and the resulting mixture was stirred for 15 min.
Extraction with CH2Cl2 (3 × 30 mL), drying of the organic
phase over Na2SO4 (with addition of 4 pellets of activated
charcoal) and removal of the solvent gave the crude product. It
was recrystallized from toluene/CH2Cl2 by layering of hexane
on top to yield 0.607 g catalyst 6be (1.44 mmol, 58%) in the
form of colorless crystals with mp: 148 – 150 °C. 1H NMR (400
MHz, CDCl3) δ [ppm] = 10.49 (s, 1H), 7.95 (d, J = 6.3 Hz, 2H),
7.77 (d, J = 8.1 Hz, 2H), 7.69 – 7.51 (m, 4H, H-13), 7.10 (d, J
= 8.0 Hz, 2H), 6.73 (d, J = 6.4 Hz, 2H), 4.49 (q, J = 7.3 Hz, 4H),
2.27 (s, 3H), 1.56 (t, J = 7.3 Hz, 6H). 13C{1H} NMR (101 MHz,
CDCl3) δ [ppm] = 156.9, 149.4, 142.3, 140.3, 131.2, 129.0,
127.1, 126.6, 115.9, 113.0, 42.9, 21.4, 14.8. Elemental analysis:
C23H26N4O2S (422.55 g mol−1): Calc. (%): C, 65.38; H, 6.20; N,
13.26; S, 7.59; found (%): C, 65.29; H, 6.18; N, 13.18; S, 7.71.
131.2, 128.5, 127.2, 115.9, 113.6, 113.1, 55.4, 43.0, 14.9. IR
−1
휈
(ATR): (cm ) = 3057 (vw), 1556 (s), 1568 (m), 1520 (w),
1484 (s), 1432 (m), 1350 (vw), 1300 (s), 1252 (s), 1225 (s),
1120 (vs), 1081 (vs), 1030 (m), 1011 (w) 990 (s), 971 (s), 851
(vw), 822 (s), 805 (s), 780 (m), 756 (s), 667 (w). Elemental
analysis: C23H26N4O3S (438.55 g mol−1): Calc. (%): C, 62.99;
H, 5.98; N, 12.78; S, 7.31; found (%): C, 62.70; H, 5.81; N,
+
12.71; S, 7.35. HRMS (ESI) m/z: [M]+ calcd for C11H15N2 ,
175.1230; found, 175.1231. [M]− calcd for C12H11N2O3S−,
263.0496; found, 263.0500.
+
HRMS (ESI) m/z: [M]+ calcd for C11H15N2 , 175.1230; found,
Tetraphenylphosphonium ((4-methoxyphenyl)sulfonyl)(pyri-
din-4-yl) amide (6cg). 0.132 g NaOH (2.0 mmol 1.1 eq) were
dissolved in 10 mL H2O and the solution was added to 0.793 g
sulfonamide 8c (3.0 mmol, 1.0 eq). The mixture was stirred at
room temperature for 15 min forming a milky suspension.
Tetraphenylphosphonium bromide (1.26 g, 3 mmol 1.0 eq) was
added with 10 mL of H2O and stirring was continued for 10 min.
Addition of 2 mL of toluene and 7 mL of CH2Cl2 caused
separation of two clear phases which were extracted with 40 mL
of CH2Cl2. The organic phases were dried over MgSO4 (under
addition of 10 pellets of activated charcoal) and removal of the
solvents gave the crude product as a sticky, colorless foam.
Crystallization from a mixture of 10 mL toluene and 8 mL
CH2Cl2 by layering of 10 mL of toluene on top yielded 1.037 g
(1.72 mmol, 57%) of catalyst 6cg in the form of colorless
175.1230. [M]− calcd for C12H11N2O2S−, 247.0547; found,
247.0545.
Benzyltriphenylphosphonium pyridin-4-yl(tosyl) amide
(6bf). 0.80 g Sulfonamide 8b (3.2 mmol, 1.0 eq) were added to
a solution of 0.141 g sodium hydroxide (3.52 mmol, 1.2 eq) in
5 mL H2O. 1.39 g Benzyltriphenylphosphonium bromide were
added with 12 mL of CH2Cl2 and the mixture was stirred at
room temperature for 30 min. Extraction with CH2Cl2, drying
of the organic phase over Na2SO4 and removal of the solvent
gave the crude product. It was dissolved in 10 mL of CH2Cl2,
upon which were layered 10 mL of toluene and 3 mL of hexane
to grow crystals overnight. This yielded 1.228 g catalyst 6bf
(2.04 mmol, 64%) in the form of colorless crystals with mp: 197
– 200 °C. 1H NMR (400 MHz, CDCl3) δ [ppm] = 7.84 (d, J =
6.4 Hz, 2H), 7.77 – 7.65 (m, 5H), 7.58 – 7.43 (m, 12H), 7.22 –
7.13 (m, 1H), 7.05 (t, J = 7.6 Hz, 2H), 7.01 (d, J = 8.0 Hz, 2H),
6.84 (d, J = 7.6 Hz, 2H), 6.73 (d, J = 6.4 Hz, 2H), 4.78 (d, J =
14.2 Hz, 2H), 2.23 (s, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ
[ppm] = 157.7, 148.7, 143.1, 139.6, 135.2 (d, J = 3.0 Hz), 134.1
(d, J = 9.7 Hz), 131.3 (d, J = 5.5 Hz), 130.3 (d, J = 12.6 Hz),
129.0 (d, J = 3.3 Hz), 128.7, 128.6 (d, J = 3.8 Hz), 126.8 (d, J =
8.7 Hz), 126.8, 117.4 (d, J = 85.8 Hz), 116.2, 30.5 (d, J = 47.7
1
crystals with mp: 153-156 °C. H NMR (400 MHz, CDCl3) δ
[ppm] = 7.88 – 7.75 (m, 8H), 7.70 (td, J = 7.8, 3.6 Hz, 8H), 7.53
(dd, J = 13.0, 7.5 Hz, 8H), 6.75 (d, J = 6.4 Hz, 2H), 6.72 (d, J =
8.8 Hz, 2H), 3.70 (s, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ
[ppm] = 160.4, 157.8, 148.9, 138.8, 135.9 (d, J = 3.0 Hz), 134.4
(d, J = 10.3 Hz), 130.8 (d, J = 12.9 Hz), 128.6, 117.4 (d, J =
89.5 Hz), 116.2, 113.1, 55.3. 31P NMR (162 MHz, CDCl3) δ
−1
휈
[ppm] = +23.06. IR (ATR): (cm ) = 3056 (vw), 1590 (m),
Hz), 21.4. 31P{1H} NMR (162 MHz, CDCl3) δ [ppm] = +22.7.
1484 (m), 1434 (m), 1317 (s), 1241 (s), 1238 (s), 1168 (w), 1123
(s) 1105 (s), 1084 (s), 1026 (w), 986 (s), 957 (s), 829 (m), 808
(m), 748 (w), 721 (vs), 692 (m), 661 (w). Elemental analysis:
C36H31N2O3PS (602.69 g mol−1): Calc. (%): C, 71.74; H, 5.18;
N, 4.65; S, 5.32; Found (%):C, 71.00; H, 5.01; N, 4.55; S, 5.57.
HRMS (ESI) m/z: [M]+ calcd for: C24H20P+, 339.1297; found,
−1
휈
IR (ATR): (cm ) = 2938 (vw), 1980 (vw), 1586 (s), 1493 (m),
1478 (m), 1436 (m), 1308 (vs), 1219 (s) 1208 (m), 1121 (vs),
1090 (vs), 991 (s), 947 (m), 836 (m), 815 (w), 782 (w), 750 (vs),
719 (m), 691 (s), 666 (m), 656 (m). Elemental analysis:
C37H33N2O2PS (600.72 g mol−1): Calc. (%): C, 73.98; H, 5.54;
ACS Paragon Plus Environment